RARE DISEASE
Benign tumor of fallopian tubes
Benign tumor of fallopian tubes
Benign tumor of fallopian tubes
Drug discovery
0
drugs
With orphan designations
Overview
Benign fallopian tube tumors are rare non-metastasizing neoplasms arising from tubal epithelium or stromal tissue, including serous adenofibromas, papillomas, and mature teratomas [1][5][14]. Most cases are asymptomatic, though some present with tubal obstruction, pelvic pain, or incidental findings during surgery for unrelated conditions [1][5][14]. Diagnosis often requires histopathological confirmation after imaging detects adnexal masses.
Categories: rare gynecological and obstetric diseases, rare neoplastic diseases
Research Papers
55 drug discovery papers about Benign tumor of fallopian tubes, with 2 first-in-class emerging drug candidates forecasted to outperform the average preclinical success rate. Recent publications:
55 drug discovery papers about Benign tumor of fallopian tubes, with 2 first-in-class emerging drug candidates forecasted to outperform the average preclinical success rate. Recent publications:
categories:
Small molecules
antibodies
2023-02-24 | Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tube.
Immune cell trafficking and surveillance within the ovary and fallopian tube are thought to impact fertility and also tumorigenesis in those organs. However, little is known of how native cells of the ovary and fallopian tube interact with resident immune cells. Interaction of the Programmed Cell Death Protein-1 (PD-1/PDCD-1/CD279) checkpoint with PD-L1 is associated with downregulated immune response. We have begun to address the question of whether PD-1 ligand or its receptors (PD-L1/-L2) can regulate immune cell function in these tissues of the female reproductive tract. PD-1 and ligand protein expression was evaluated in human ovary and fallopian tube specimens, the latter of which included stages of tubal cell transformation and early tumorigenesis. Ovarian expression analysis included the determination of the proteins in human follicular fluid (HFF) specimens collected during in vitro fertilization procedures. Finally, checkpoint bioactivity of HFF was determined by treatment of separately-isolated human T cells and the measurement of interferon gamma (IFNγ). We show that membrane bound and soluble variants of PD-1 and ligands are expressed by permanent constituent cell types of the human ovary and fallopian tube, including granulosa cells and oocytes. PD-1 and soluble ligands were present in HFF at bioactive levels that control T cell PD-1 activation and IFNγ production; full-length checkpoint proteins were found to be highly enriched in HFF exosome fractions. The detection of PD-1 checkpoint proteins in the human ovary and fallopian tube suggests that the pathway is involved in immunomodulation during folliculogenesis, the window of ovulation, and subsequent egg and embryo immune-privilege. Immunomodulatory action of receptor and ligands in HFF exosomes is suggestive of an acute checkpoint role during ovulation. This is the first study in the role of PD-1 checkpoint proteins in human tubo-ovarian specimens and the first examination of its potential regulatory action in the contexts of normal and assisted reproduction.
2022-11-29 | Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
Outcomes with and without bevacizumab as first-line chemotherapy in Japanese-only ovarian cancer patients have not been reported. In this study, we report a retrospective study conducted at the Tohoku Gynecologic Cancer Unit. The study included 453 patients with stage III/IV ovarian, fallopian tube, and primary peritoneal cancer who received first-line platinum-based chemotherapy. The patients were divided into two groups: bevacizumab (168 patients) and without bevacizumab (285 patients). The primary endpoint was the rate of platinum-resistant recurrence and the secondary endpoints were the antitumor response, progression-free survival, overall survival, and adverse events. The objective response rates for patients with measurable diseases treated with and without bevacizumab were 84.5% and 73.0%, respectively (P = 0.0066). Platinum-resistant recurrence in the groups treated with and without bevacizumab was noted in 31 (18.4%) and 111 (38.6%) patients, respectively (P < 0.0001). The median progression-free survival for the bevacizumab and without bevacizumab groups was 23 and 15 months, respectively (P = 0.0002), and the median overall survival was not reached and 49 months, respectively (P = 0.0005). Hypertension of grade 3 or higher was observed in 21 patients (12.5%) in the bevacizumab group (P < 0.001), and proteinuria was observed in 18 patients (10.7%) and 1 patient (0.3%) in the bevacizumab and without bevacizumab groups, respectively (P < 0.001). Intestinal perforation was observed in only one patient (0.6%) in the bevacizumab group. Combination and maintenance with bevacizumab in primary chemotherapy for advanced ovarian, fallopian tube, and primary peritoneal cancer was effective in reducing platinum-resistant recurrence rates and prolonging progression-free and overall survival.
2019-07-12 | IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation.
The fallopian tube fimbria is regarded as the main tissue of origin and incessant ovulation as the main risk factor of ovarian high-grade serous carcinoma. Previously, we discovered the tumorigenesis activity of human ovulatory follicular fluid (FF) upon injection to the mammary fat pad of Trp53-null mice. We also found a mutagenesis activity of FF-ROS and a apoptosis-rescuing activity of Hb from retrograde menstruation. However, neither of them can explain the tumorigenesis activities of FF. From two cohorts of ovulatory FF retrieved from IVF patients, the main growth factor responsible for the transformation of human fimbrial epithelial cells was identified. Mechanism of activation, ways of signal transduction of the growth factor, as well as the cellular and genetic phenotypes of the malignant transformation was characterized. In this study, we showed that insulin-like growth factor (IGF)-axis proteins, including IGFBP-bound IGF2 as well as the IGFBP-lytic enzyme PAPP-A, are abundantly present in FF. Upon engaging with glycosaminoglycans on the membrane of fimbrial epithelial cells, PAPP-A cleaves IGFBPs and releases IGF2 to bind with IGF-1R. Through the IGF-1R/AKT/mTOR and IGF-1R/AKT/NANOG pathways, FF-IGF leads to stemness and survival, and in the case of TP53/Rb or TP53/CCNE1 loss, to clonal expansion and malignant transformation of fimbrial epithelial cells. By depleting each IGF axis component from FF, we proved that IGF2, IGFBP2/6, and PAPP-A are all essential and confer the majority of the transformation and regeneration activities. This study revealed that the FF-IGF axis functions to regenerate tissue damage after ovulation and promote the transformation of fimbrial epithelial cells that have been initiated by p53- and Rb-pathway disruptions. FUND: The study was supported by grants of the Ministry of Science and Technology, Taiwan (MOST 106-2314-B-303-001-MY2; MOST 105-2314-B-303-017-MY2; MOST 107-2314-B-303-013-MY3), and Buddhist Tzu Chi General Hospital, Taiwan (TCMMP104-04-01).
2017-07-31 | Transplantation Into the Mouse Ovarian Fat Pad.
Orthotopic transplantation assays in mice are invaluable for studies of cell regeneration and neoplastic transformation. Common approaches for orthotopic transplantation of ovarian surface and tubal epithelia include intraperitoneal and intrabursal administration of cells. The respective limitations of these methods include poorly defined location of injected cells and limited space volume. Furthermore, they are poorly suited for long-term structural preservation of transplanted organs. To address these challenges, we have developed an alternative approach, which is based on the introduction of cells and tissue fragments into the mouse fat pad. The mouse ovarian fat pad is located in the immediate vicinity of the ovary and uterine tube (aka oviduct, fallopian tube), and provides a familiar microenvironment for cells and tissues of these organs. In our approach fluorescence-labeled mouse and human cells, and fragments of the uterine tube are engrafted by using minimally traumatic dorsal incision surgery. Transplanted cells and their outgrowths are easily located in the ovarian fat pad for over 40 days. Long-term transplantation of the entire uterine tube allows correct preservation of all principle tissue components, and does not result in adverse side effects, such as fibrosis and inflammation. Our approach should be uniquely applicable for answering important biological questions such as differentiation, regenerative and neoplastic potential of specific cell populations. Furthermore, it should be suitable for studies of microenvironmental factors in normal development and cancer.
2007-06-14 | Novel biological and possible applicable roles of LH/hCG receptor.
Luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptors are widely expressed in gonadal cells, however, the presence of these receptors has also been demonstrated in several other non-gonadal female and male tissues. The expression level of non-gonadal LH/hCG receptors is much lower than in gonads, although their expression is regulated by similar mechanisms and they also exert biological effects using similar signaling pathways. Hormonally regulated LH/hCG receptor expression in the oviduct suggests that LH could be involved in the regulation of its contraction, gametes/embryos transport and synchronization of the fertilization. One of the major roles of the myometrial LH/hCG receptors may also be the stimulation of growth and maintenance of the uterine relaxation during pregnancy. In pigs, LH seems to be one of the pleiotropic factors which influence the endometrial prostaglandin F(2alpha) synthesis and initiation of the luteolysis. The LH/hCG receptor expression in several cancer cells provides new possibilities for developing new strategies for targeted cancer therapy based on lytic LH/hCG conjugates.
small molecules
2025-11-19 | Age, lifestyle, and disease affect ciliary transport in the human fallopian tube.
The synchronized beating of ciliated cells within the human fallopian tube is crucial for the transport of the oocyte and the early embryo. To date, the precise effects of age, lifestyle, and disease on ciliary beating in the human fallopian tube are still unknown. Therefore, we set out to evaluate the effects of cycle stage, age, BMI, smoking, and alcohol, as well as the impact of ovarian cysts, uterine fibroids (myomas), cervical cancer, and endometrial cancer on human tubal ciliary beat frequency (CBF). Samples were obtained from control patients undergoing risk reduction surgery as well as from patients with ovarian cysts, benign myomas, as well as from patients with cervical cancer and endometrial cancer. Tubal samples were obtained during hysterectomy with salpingo-oophorectomy and examined using quantitative digital live cell imaging under near in vivo conditions and in real-time. Our results showed that tubal CBF was independent of cycle stage and anatomical location in the oviduct. There was a significant relationship between patient age and CBF (< 45 years Spearman's rho=-0.708, p = < 0.001 and > 45 years Spearman's rho=-0.752, p = < 0.001). Smoking caused a significant increase in CBF (generalised linear model, p = 0.025), whereas regular alcohol consumption had no effect. Increased BMI was associated with significantly decreased CBF (Spearman's rho=-0.543, p = 0.024). CBF was also significantly decreased in cycling patients affected by ovarian cysts (generalised linear model for repeated measurements, p = 0.004), in patients with uterine myomas (generalised linear model, p = 0.027), as well as in patients with cervical cancer (cycling patients, generalised linear model, p = 0.002) and endometrial cancer (menopausal patients, generalised linear model, p = 0.003). Overall, our results show that tubal ciliary function is impaired by obesity and smoking, as well as by benign myomas and malignant gynaecological cancer. Altered CBF impairs proper embryo transport speed, decreasing the chance of successful pregnancy. Thus, modulating early embryo transport might be a valuable tool for optimizing the success rates of assisted reproductive technologies (ART) both in infertile healthy patients as well as in young cervical cancer patients.
2025-07-10 | Bilateral Borderline Serous Tumor of Fallopian Tube in a Child With Klippel-Trenaunay Syndrome: An Exceptionally Rare Combination.
Klippel-Trenaunay syndrome (KTS) is a rare overgrowth disorder characterized by capillary malformations, vascular anomalies, and limb length discrepancies. It is a congenital, mostly sporadic disorder with unknown pathogenesis, though recent studies have shown an association with somatic mosaic-activating mutations in the PIK3CA gene. The prognosis is variable, depending on the clinical presentation. Visceral involvement in KTS is rare, usually in the form of hemangiomas or venous malformations. Varied neoplastic pathologies have been reported in KTS; however, unlike other overgrowth syndromes, no clear association between KTS and malignancy has so far been elucidated. We report herein an account of a 2-yr-old female child with KTS who presented with abdominal distention and was diagnosed to have a serous borderline tumor (SBT) of bilateral fallopian tubes. Fallopian tube SBT is exceptionally rare and, to the best of our knowledge, has only been reported once previously in a premenarchal patient, who, incidentally, also had KTS. Bilateral fallopian tube involvement in a pediatric SBT has not been described hitherto.
2025-02-09 | Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures.
Oral contraceptives reduce ovarian cancer risk, but the mechanism of risk reduction is not understood. We examined whether oral contraceptive pill (OCP) use influences p53 signatures, which are putative early fallopian tube precursors for high-grade serous ovarian carcinomas. For this retrospective cohort (n = 250) of subjects aged over 50 years who had fallopian tubes removed at the time of a benign gynecologic procedure, we used health records to identify 72 patients who used OCPs for at least 5 years and 178 subjects with no history of OCP use. Immunohistochemistry for p53 was performed on all fallopian tube sections, with 8 individuals removed for lack of identifiable tissue. p53 Signatures were identified and stratified based on size. Logistic regressions were run to estimate the association between OCP use and p53 lesion and lesion size. There was no difference in the occurrence of p53 lesions with 20 of 70 of OCP users (28.6%) and 57 of 172 of those with no history of OCP use (33.1%). Subjects who used OCPs were more likely to have a small lesion (OR 1.98, 95% CI 1.03 to 3.83) and had decreased risk of having a medium/large lesion (OR 0.38, 95% CI 0.18 to 0.79). A total of 2 serous tubal intraepithelial lesions and 2 serous tubal intraepithelial carcinomas were identified in OCP-naive patients, whereas none were found in those with a history of OCP use. OCP exposure was associated with a shift toward smaller p53 lesion size but was not found to be associated with a difference in the number of p53 lesions between OCP-exposed and unexposed patients. Future research should examine whether OCP use reduces proliferation and clonal expansion of p53 signature lesions toward higher risk precursors and, eventually, cancer. There were no serous tubal intraepithelial lesions and serous tubal intraepithelial carcinomas in patients with OCP exposure.
2025-01-29 | Fallopian Tube Papilloma: A Systematic Review of Case Reports.
Fallopian tube papilloma (FTP) is one of the benign lesions of the oviduct and is a rare proliferative epithelial lesion. Low incidence and underreporting of the disease limit our knowledge of these lesions. These lesions cause a diagnostic dilemma and need to be differentiated from several other conditions of the fallopian tubes both benign and malignant. Fallopian tube papilloma may lead to tubal obstruction and can be a cause of subfertility, ectopic gestation, or mass lesions in the fallopian tubes and hence should be considered as an important differential while managing these women. A high index of suspicion is required, and the final diagnosis can only be made after histopathological results. The reporting of such lesions is important to know the true prevalence of these tumors and to increase our knowledge about these benign neoplasms. This systematic review of case reports was done to enhance knowledge regarding the etiology, natural course, complication, and recurrence of FTP. An electronic search of Scopus, Pubmed, Embase, Web of Science, Google Scholar, and other databases was conducted for case reports and case series published in English from inception till January 2024.
2025-01-24 | Walthard Cell Nests Leading to 18 F-FDG Increased Uptake of Fallopian Tube.
We present 18 F-FDG PET/CT findings of fallopian tube with Walthard cell nests. The images revealed a thickening of the bilateral fallopian tubes with increased FDG uptake. Malignant tumor or tuberculosis of the fallopian tube was suspected. Histopathology suggested fallopian tube with Walthard cell nests.
antibodies
2023-02-24 | Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tube.
Immune cell trafficking and surveillance within the ovary and fallopian tube are thought to impact fertility and also tumorigenesis in those organs. However, little is known of how native cells of the ovary and fallopian tube interact with resident immune cells. Interaction of the Programmed Cell Death Protein-1 (PD-1/PDCD-1/CD279) checkpoint with PD-L1 is associated with downregulated immune response. We have begun to address the question of whether PD-1 ligand or its receptors (PD-L1/-L2) can regulate immune cell function in these tissues of the female reproductive tract. PD-1 and ligand protein expression was evaluated in human ovary and fallopian tube specimens, the latter of which included stages of tubal cell transformation and early tumorigenesis. Ovarian expression analysis included the determination of the proteins in human follicular fluid (HFF) specimens collected during in vitro fertilization procedures. Finally, checkpoint bioactivity of HFF was determined by treatment of separately-isolated human T cells and the measurement of interferon gamma (IFNγ). We show that membrane bound and soluble variants of PD-1 and ligands are expressed by permanent constituent cell types of the human ovary and fallopian tube, including granulosa cells and oocytes. PD-1 and soluble ligands were present in HFF at bioactive levels that control T cell PD-1 activation and IFNγ production; full-length checkpoint proteins were found to be highly enriched in HFF exosome fractions. The detection of PD-1 checkpoint proteins in the human ovary and fallopian tube suggests that the pathway is involved in immunomodulation during folliculogenesis, the window of ovulation, and subsequent egg and embryo immune-privilege. Immunomodulatory action of receptor and ligands in HFF exosomes is suggestive of an acute checkpoint role during ovulation. This is the first study in the role of PD-1 checkpoint proteins in human tubo-ovarian specimens and the first examination of its potential regulatory action in the contexts of normal and assisted reproduction.
2022-11-29 | Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
Outcomes with and without bevacizumab as first-line chemotherapy in Japanese-only ovarian cancer patients have not been reported. In this study, we report a retrospective study conducted at the Tohoku Gynecologic Cancer Unit. The study included 453 patients with stage III/IV ovarian, fallopian tube, and primary peritoneal cancer who received first-line platinum-based chemotherapy. The patients were divided into two groups: bevacizumab (168 patients) and without bevacizumab (285 patients). The primary endpoint was the rate of platinum-resistant recurrence and the secondary endpoints were the antitumor response, progression-free survival, overall survival, and adverse events. The objective response rates for patients with measurable diseases treated with and without bevacizumab were 84.5% and 73.0%, respectively (P = 0.0066). Platinum-resistant recurrence in the groups treated with and without bevacizumab was noted in 31 (18.4%) and 111 (38.6%) patients, respectively (P < 0.0001). The median progression-free survival for the bevacizumab and without bevacizumab groups was 23 and 15 months, respectively (P = 0.0002), and the median overall survival was not reached and 49 months, respectively (P = 0.0005). Hypertension of grade 3 or higher was observed in 21 patients (12.5%) in the bevacizumab group (P < 0.001), and proteinuria was observed in 18 patients (10.7%) and 1 patient (0.3%) in the bevacizumab and without bevacizumab groups, respectively (P < 0.001). Intestinal perforation was observed in only one patient (0.6%) in the bevacizumab group. Combination and maintenance with bevacizumab in primary chemotherapy for advanced ovarian, fallopian tube, and primary peritoneal cancer was effective in reducing platinum-resistant recurrence rates and prolonging progression-free and overall survival.
2019-07-12 | IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation.
The fallopian tube fimbria is regarded as the main tissue of origin and incessant ovulation as the main risk factor of ovarian high-grade serous carcinoma. Previously, we discovered the tumorigenesis activity of human ovulatory follicular fluid (FF) upon injection to the mammary fat pad of Trp53-null mice. We also found a mutagenesis activity of FF-ROS and a apoptosis-rescuing activity of Hb from retrograde menstruation. However, neither of them can explain the tumorigenesis activities of FF. From two cohorts of ovulatory FF retrieved from IVF patients, the main growth factor responsible for the transformation of human fimbrial epithelial cells was identified. Mechanism of activation, ways of signal transduction of the growth factor, as well as the cellular and genetic phenotypes of the malignant transformation was characterized. In this study, we showed that insulin-like growth factor (IGF)-axis proteins, including IGFBP-bound IGF2 as well as the IGFBP-lytic enzyme PAPP-A, are abundantly present in FF. Upon engaging with glycosaminoglycans on the membrane of fimbrial epithelial cells, PAPP-A cleaves IGFBPs and releases IGF2 to bind with IGF-1R. Through the IGF-1R/AKT/mTOR and IGF-1R/AKT/NANOG pathways, FF-IGF leads to stemness and survival, and in the case of TP53/Rb or TP53/CCNE1 loss, to clonal expansion and malignant transformation of fimbrial epithelial cells. By depleting each IGF axis component from FF, we proved that IGF2, IGFBP2/6, and PAPP-A are all essential and confer the majority of the transformation and regeneration activities. This study revealed that the FF-IGF axis functions to regenerate tissue damage after ovulation and promote the transformation of fimbrial epithelial cells that have been initiated by p53- and Rb-pathway disruptions. FUND: The study was supported by grants of the Ministry of Science and Technology, Taiwan (MOST 106-2314-B-303-001-MY2; MOST 105-2314-B-303-017-MY2; MOST 107-2314-B-303-013-MY3), and Buddhist Tzu Chi General Hospital, Taiwan (TCMMP104-04-01).
2017-07-31 | Transplantation Into the Mouse Ovarian Fat Pad.
Orthotopic transplantation assays in mice are invaluable for studies of cell regeneration and neoplastic transformation. Common approaches for orthotopic transplantation of ovarian surface and tubal epithelia include intraperitoneal and intrabursal administration of cells. The respective limitations of these methods include poorly defined location of injected cells and limited space volume. Furthermore, they are poorly suited for long-term structural preservation of transplanted organs. To address these challenges, we have developed an alternative approach, which is based on the introduction of cells and tissue fragments into the mouse fat pad. The mouse ovarian fat pad is located in the immediate vicinity of the ovary and uterine tube (aka oviduct, fallopian tube), and provides a familiar microenvironment for cells and tissues of these organs. In our approach fluorescence-labeled mouse and human cells, and fragments of the uterine tube are engrafted by using minimally traumatic dorsal incision surgery. Transplanted cells and their outgrowths are easily located in the ovarian fat pad for over 40 days. Long-term transplantation of the entire uterine tube allows correct preservation of all principle tissue components, and does not result in adverse side effects, such as fibrosis and inflammation. Our approach should be uniquely applicable for answering important biological questions such as differentiation, regenerative and neoplastic potential of specific cell populations. Furthermore, it should be suitable for studies of microenvironmental factors in normal development and cancer.
2007-06-14 | Novel biological and possible applicable roles of LH/hCG receptor.
Luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptors are widely expressed in gonadal cells, however, the presence of these receptors has also been demonstrated in several other non-gonadal female and male tissues. The expression level of non-gonadal LH/hCG receptors is much lower than in gonads, although their expression is regulated by similar mechanisms and they also exert biological effects using similar signaling pathways. Hormonally regulated LH/hCG receptor expression in the oviduct suggests that LH could be involved in the regulation of its contraction, gametes/embryos transport and synchronization of the fertilization. One of the major roles of the myometrial LH/hCG receptors may also be the stimulation of growth and maintenance of the uterine relaxation during pregnancy. In pigs, LH seems to be one of the pleiotropic factors which influence the endometrial prostaglandin F(2alpha) synthesis and initiation of the luteolysis. The LH/hCG receptor expression in several cancer cells provides new possibilities for developing new strategies for targeted cancer therapy based on lytic LH/hCG conjugates.
small molecules
2025-11-19 | Age, lifestyle, and disease affect ciliary transport in the human fallopian tube.
The synchronized beating of ciliated cells within the human fallopian tube is crucial for the transport of the oocyte and the early embryo. To date, the precise effects of age, lifestyle, and disease on ciliary beating in the human fallopian tube are still unknown. Therefore, we set out to evaluate the effects of cycle stage, age, BMI, smoking, and alcohol, as well as the impact of ovarian cysts, uterine fibroids (myomas), cervical cancer, and endometrial cancer on human tubal ciliary beat frequency (CBF). Samples were obtained from control patients undergoing risk reduction surgery as well as from patients with ovarian cysts, benign myomas, as well as from patients with cervical cancer and endometrial cancer. Tubal samples were obtained during hysterectomy with salpingo-oophorectomy and examined using quantitative digital live cell imaging under near in vivo conditions and in real-time. Our results showed that tubal CBF was independent of cycle stage and anatomical location in the oviduct. There was a significant relationship between patient age and CBF (< 45 years Spearman's rho=-0.708, p = < 0.001 and > 45 years Spearman's rho=-0.752, p = < 0.001). Smoking caused a significant increase in CBF (generalised linear model, p = 0.025), whereas regular alcohol consumption had no effect. Increased BMI was associated with significantly decreased CBF (Spearman's rho=-0.543, p = 0.024). CBF was also significantly decreased in cycling patients affected by ovarian cysts (generalised linear model for repeated measurements, p = 0.004), in patients with uterine myomas (generalised linear model, p = 0.027), as well as in patients with cervical cancer (cycling patients, generalised linear model, p = 0.002) and endometrial cancer (menopausal patients, generalised linear model, p = 0.003). Overall, our results show that tubal ciliary function is impaired by obesity and smoking, as well as by benign myomas and malignant gynaecological cancer. Altered CBF impairs proper embryo transport speed, decreasing the chance of successful pregnancy. Thus, modulating early embryo transport might be a valuable tool for optimizing the success rates of assisted reproductive technologies (ART) both in infertile healthy patients as well as in young cervical cancer patients.
2025-07-10 | Bilateral Borderline Serous Tumor of Fallopian Tube in a Child With Klippel-Trenaunay Syndrome: An Exceptionally Rare Combination.
Klippel-Trenaunay syndrome (KTS) is a rare overgrowth disorder characterized by capillary malformations, vascular anomalies, and limb length discrepancies. It is a congenital, mostly sporadic disorder with unknown pathogenesis, though recent studies have shown an association with somatic mosaic-activating mutations in the PIK3CA gene. The prognosis is variable, depending on the clinical presentation. Visceral involvement in KTS is rare, usually in the form of hemangiomas or venous malformations. Varied neoplastic pathologies have been reported in KTS; however, unlike other overgrowth syndromes, no clear association between KTS and malignancy has so far been elucidated. We report herein an account of a 2-yr-old female child with KTS who presented with abdominal distention and was diagnosed to have a serous borderline tumor (SBT) of bilateral fallopian tubes. Fallopian tube SBT is exceptionally rare and, to the best of our knowledge, has only been reported once previously in a premenarchal patient, who, incidentally, also had KTS. Bilateral fallopian tube involvement in a pediatric SBT has not been described hitherto.
2025-02-09 | Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures.
Oral contraceptives reduce ovarian cancer risk, but the mechanism of risk reduction is not understood. We examined whether oral contraceptive pill (OCP) use influences p53 signatures, which are putative early fallopian tube precursors for high-grade serous ovarian carcinomas. For this retrospective cohort (n = 250) of subjects aged over 50 years who had fallopian tubes removed at the time of a benign gynecologic procedure, we used health records to identify 72 patients who used OCPs for at least 5 years and 178 subjects with no history of OCP use. Immunohistochemistry for p53 was performed on all fallopian tube sections, with 8 individuals removed for lack of identifiable tissue. p53 Signatures were identified and stratified based on size. Logistic regressions were run to estimate the association between OCP use and p53 lesion and lesion size. There was no difference in the occurrence of p53 lesions with 20 of 70 of OCP users (28.6%) and 57 of 172 of those with no history of OCP use (33.1%). Subjects who used OCPs were more likely to have a small lesion (OR 1.98, 95% CI 1.03 to 3.83) and had decreased risk of having a medium/large lesion (OR 0.38, 95% CI 0.18 to 0.79). A total of 2 serous tubal intraepithelial lesions and 2 serous tubal intraepithelial carcinomas were identified in OCP-naive patients, whereas none were found in those with a history of OCP use. OCP exposure was associated with a shift toward smaller p53 lesion size but was not found to be associated with a difference in the number of p53 lesions between OCP-exposed and unexposed patients. Future research should examine whether OCP use reduces proliferation and clonal expansion of p53 signature lesions toward higher risk precursors and, eventually, cancer. There were no serous tubal intraepithelial lesions and serous tubal intraepithelial carcinomas in patients with OCP exposure.
2025-01-29 | Fallopian Tube Papilloma: A Systematic Review of Case Reports.
Fallopian tube papilloma (FTP) is one of the benign lesions of the oviduct and is a rare proliferative epithelial lesion. Low incidence and underreporting of the disease limit our knowledge of these lesions. These lesions cause a diagnostic dilemma and need to be differentiated from several other conditions of the fallopian tubes both benign and malignant. Fallopian tube papilloma may lead to tubal obstruction and can be a cause of subfertility, ectopic gestation, or mass lesions in the fallopian tubes and hence should be considered as an important differential while managing these women. A high index of suspicion is required, and the final diagnosis can only be made after histopathological results. The reporting of such lesions is important to know the true prevalence of these tumors and to increase our knowledge about these benign neoplasms. This systematic review of case reports was done to enhance knowledge regarding the etiology, natural course, complication, and recurrence of FTP. An electronic search of Scopus, Pubmed, Embase, Web of Science, Google Scholar, and other databases was conducted for case reports and case series published in English from inception till January 2024.
2025-01-24 | Walthard Cell Nests Leading to 18 F-FDG Increased Uptake of Fallopian Tube.
We present 18 F-FDG PET/CT findings of fallopian tube with Walthard cell nests. The images revealed a thickening of the bilateral fallopian tubes with increased FDG uptake. Malignant tumor or tuberculosis of the fallopian tube was suspected. Histopathology suggested fallopian tube with Walthard cell nests.
Access all drug discovery papers and probability of success in trials forecasts:
Access all drug discovery papers and probability of success in trials forecasts:
Drug Discovery Landscape
0 orphan drug designations.
0 orphan drug designations.
Let's accelerate rare disease drug discovery
Let's accelerate drug discovery
Get access to Explority AI’s forecasts to outperform average preclinical success rates. Whether you’re expanding your R&D pipeline, evaluating a partnership, or simply have a question — we’d love to hear from you.